Morse, M., Hobeika, A., Osada, T., Berglund, P., Negri, S., Niedzwiecki, D., … Lyerly, H. K. (2010). Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells. In Journal of Clinical Oncology (Vol. 28, pp. 2544–2544). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.2544

Morse, M., A. Hobeika, T. Osada, P. Berglund, S. Negri, D. Niedzwiecki, B. Hubby, B. K. Burnett, T. M. Clay, and H. K. Lyerly. “Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells.” In Journal of Clinical Oncology, 28:2544–2544. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.2544.

Morse M, Hobeika A, Osada T, Berglund P, Negri S, Niedzwiecki D, et al. Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 2544–2544.

Morse, M., et al. “Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. 2544–2544. Crossref, doi:10.1200/jco.2010.28.15_suppl.2544.

Morse M, Hobeika A, Osada T, Berglund P, Negri S, Niedzwiecki D, Hubby B, Burnett BK, Clay TM, Lyerly HK. Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 2544–2544.